another approval and another zero effect on company's revenue; pristiq market size is small and ipci revenue will be negligible, if any (Odidi will likely shelf it like the last 3 generic approvals).
intersting though the price reaction. Could imagine the effect a real good news ?
Market Data 
Markets 
